Your browser doesn't support javascript.
loading
Identification of a major determinant for serine-threonine kinase phosphoacceptor specificity.
Chen, Catherine; Ha, Byung Hak; Thévenin, Anastasia F; Lou, Hua Jane; Zhang, Rong; Yip, Kevin Y; Peterson, Jeffrey R; Gerstein, Mark; Kim, Philip M; Filippakopoulos, Panagis; Knapp, Stefan; Boggon, Titus J; Turk, Benjamin E.
Afiliação
  • Chen C; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Ha BH; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Thévenin AF; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Lou HJ; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Zhang R; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Yip KY; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA; Department of Computer Science and Engineering, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
  • Peterson JR; Division of Basic Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
  • Gerstein M; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA.
  • Kim PM; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, ON M5S 3E1, Canada.
  • Filippakopoulos P; Oxford University, Nuffield Department of Clinical Medicine, Target Discovery Institute (TDI) and Structural Genomics Consortium (SGC), Oxford OX3 7FZ, UK; Ludwig Institute for Cancer Research, Old Road Campus Research Building, Oxford OX3 7DQ, UK.
  • Knapp S; Oxford University, Nuffield Department of Clinical Medicine, Target Discovery Institute (TDI) and Structural Genomics Consortium (SGC), Oxford OX3 7FZ, UK.
  • Boggon TJ; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Turk BE; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: ben.turk@yale.edu.
Mol Cell ; 53(1): 140-7, 2014 Jan 09.
Article em En | MEDLINE | ID: mdl-24374310
ABSTRACT
Eukaryotic protein kinases are generally classified as being either tyrosine or serine-threonine specific. Though not evident from inspection of their primary sequences, many serine-threonine kinases display a significant preference for serine or threonine as the phosphoacceptor residue. Here we show that a residue located in the kinase activation segment, which we term the "DFG+1" residue, acts as a major determinant for serine-threonine phosphorylation site specificity. Mutation of this residue was sufficient to switch the phosphorylation site preference for multiple kinases, including the serine-specific kinase PAK4 and the threonine-specific kinase MST4. Kinetic analysis of peptide substrate phosphorylation and crystal structures of PAK4-peptide complexes suggested that phosphoacceptor residue preference is not mediated by stronger binding of the favored substrate. Rather, favored kinase-phosphoacceptor combinations likely promote a conformation optimal for catalysis. Understanding the rules governing kinase phosphoacceptor preference allows kinases to be classified as serine or threonine specific based on their sequence.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Proteínas Serina-Treonina Quinases / Quinases Ativadas por p21 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Mol Cell Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Proteínas Serina-Treonina Quinases / Quinases Ativadas por p21 Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Mol Cell Ano de publicação: 2014 Tipo de documento: Article